The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.
about
Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis preventionGlioblastoma Circulating Cells: Reality, Trap or Illusion?Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistancec-Jun N-Terminal Kinases Mediate a Wide Range of Targets in the Metastatic CascadeThe emerging molecular machinery and therapeutic targets of metastasisThe DAN family: modulators of TGF-β signaling and beyondMechanisms of disseminated cancer cell dormancy: an awakening fieldDistinctive properties of metastasis-initiating cellsTumor cell dormancyMetastatic colonization by circulating tumour cellsTGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and MetastasisMechanisms involved in breast cancer liver metastasisMicroenvironmental regulation of tumor progression and metastasisStructure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists.Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy.Molecular pathways: niches in metastatic dormancyAn integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancerConcise review: breast cancer stem cells: regulatory networks, stem cell niches, and disease relevanceThe lung metastatic niche.Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation.SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation.Mechanisms governing metastatic dormancy and reactivation.Integrative analysis of transcriptional regulatory network and copy number variation in intrahepatic cholangiocarcinoma.Cripto-1 as a novel therapeutic target for triple negative breast cancer.Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy.Coco is a dual activity modulator of TGFβ signaling.Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growthFibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis.Inhibition of BMP signaling suppresses metastasis in mammary cancerSphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype.Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization.p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion.Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.Metastasis prevention by targeting the dormant niche.Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft modelChordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and InvasionTumor cell dissemination: emerging biological insights from animal models and cancer patients.BMP/Coco antagonism as a deterministic factor of metastasis dormancy in lung.
P2860
Q21195742-55E44D56-6204-4D55-93EB-1504D9916992Q26823823-51676715-A3B2-46C4-9BF0-65B519566908Q26824386-3CD30BEA-D903-4A03-BB09-A30BFE71B4CAQ26998420-C6169F7F-F9E1-42B0-8247-56F4FF124DD1Q27022207-FCB225BB-43B8-42FE-A874-61B81A8D6476Q27025762-88210303-4793-457D-B6AC-3E391662825AQ27027015-A0B5A481-CBF8-466A-8F9A-D85A0FAADA84Q28069801-1A5CE1B5-8C19-4D8A-99F6-885798326DCCQ28073065-6A086294-233A-4BD2-B30B-3DDE71922DDCQ28076164-0CAB5165-0FCF-4382-9A71-58BFFA792694Q28083107-BAC0BB8C-D700-47FD-9562-C7880FA7D8D1Q28084024-45FDC0E8-1643-45A6-A322-D6727D1B24D9Q29615504-985A00A6-F7FD-4C34-9EC8-F2DA2CAFB9D7Q30090227-8FB712EB-3C71-4E70-9600-8BA4AB08A661Q33671783-742AF85B-12D1-4883-BC2A-415C88F39958Q33838536-FE3888AD-D8E3-47F6-8792-C1EC50163407Q33892460-D5C82381-1EF2-46A1-AE52-2B3665D4521BQ33975619-3EE82272-C26D-4851-B73C-A89474EDC0DCQ34498908-98A03490-5CE3-4EEC-9DF6-75739C81CAB9Q34581396-E0C099F8-A756-40D5-9383-05C47C29D5CCQ34695105-146AD50E-5D04-44ED-BA59-0EEDAFCD86EEQ34778918-CE3C461E-91F3-43D8-A75E-FCB305918C36Q35162521-78A043DF-2763-450E-AFF8-C30913318DF1Q35181521-6EC32DA1-E50A-4AFB-9DE8-CB48FE7035EFQ35658975-64658672-C50C-4369-9862-D032371DEED0Q35666361-3B1EFC36-6020-44C8-A66A-E2E77961E859Q35928088-BE4DE374-3515-44B3-A287-E08BC0AFEB20Q36011433-175E92E5-FA83-4521-8AFE-6F852E575E5AQ36108833-8F620237-DCE1-4675-AA99-B01F29875DB8Q36356105-61F30AE1-642A-4174-A259-F6B37B6617B6Q36398681-1B026E16-4481-417A-94F3-144B419FD277Q36413760-21DDEA44-0619-4459-B6A5-55EAD539922DQ36480916-D2E10B6B-8F91-4A7A-96F8-436DD4CBD8B0Q36687990-405E6B63-701E-44D8-8FDF-A3F56FA16635Q36731080-362C0205-6752-443D-BA1B-8CA60E40F598Q36829245-8204C29E-20F3-4C55-849C-193A08DD6EC3Q36835474-E8ECDE5A-E760-4E72-8426-7630626D64F2Q36878808-72B6B4D4-619A-494B-9601-3B1624D30BCCQ36887350-EF98AA0E-63B1-4D16-BD68-BCBEAB51CD01Q36903161-88DEDF22-117B-4956-9629-637DF58CB156
P2860
The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.
@en
The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.
@nl
type
label
The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.
@en
The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.
@nl
prefLabel
The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.
@en
The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.
@nl
P2093
P2860
P1433
P1476
The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites.
@en
P2093
Ai Ping Lee-Lim
Ali H Brivanlou
Alin Vonica
Filippo G Giancotti
Goutam Chakraborty
Markus Decker
Qianxing Mo
Ronglai Shen
P2860
P304
P356
10.1016/J.CELL.2012.06.035
P407
P577
2012-08-01T00:00:00Z